Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis

Journal of the American Academy of Dermatology

Volumn 72, Issue 3, 2015, Pages 449-455

  Fiorentino, David F ^a   Kuo, Karen ^a   Chung, Lorinda ^a,b   Zaba, Lisa ^a   Li, Shufeng ^a   Casciola Rosen, Livia ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autoantibodies; Cutaneous Dermatomyositis Assessment and Severity Index; dermatomyositis; malignancy; phenotype; transcriptional intermediary factor 1

Indexed keywords

AUTOANTIBODY; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; TRANSCRIPTIONAL INTERMEDIARY FACTOR 1 GAMMA ANTIBODY; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR; TRIM33 PROTEIN, HUMAN;

ADULT; ADULT DISEASE; ARTHRALGIA; ARTHRITIS; ARTICLE; BACK RASH; CALCINOSIS; CANCER RISK; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE SEVERITY; FACE RASH; FEMALE; FOLLOW UP; HUMAN; HYPOPIGMENTATION; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NECK RASH; PALMOPLANTAR KERATODERMA; PAPULE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RASH; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; RISK FACTOR; SCALP RASH; SKIN DEFECT; SMOKING; TELANGIECTASIA; TERTIARY CARE CENTER; ADOLESCENT; AGED; BLOOD; CHILD; IMMUNOLOGY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84925445234     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.12.009     Document Type: Article

References (28)

1. I.N. Targoff Myositis specific autoantibodies Curr Rheumatol Rep 8 2006 196 203
2. A. Ghirardello, N. Bassi, and L. Palma Autoantibodies in polymyositis and dermatomyositis Curr Rheumatol Rep 15 2013 335
3. Z.E. Betteridge, H. Gunawardena, and N.J. McHugh Novel autoantibodies and clinical phenotypes in adult and juvenile myositis Arthritis Res Ther 13 2011 209
4. I.N. Targoff, G. Mamyrova, and E.P. Trieu A novel autoantibody to a 155-kd protein is associated with dermatomyositis Arthritis Rheum 54 2006 3682 3689
5. K. Kaji, M. Fujimoto, and M. Hasegawa Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy Rheumatology 46 2007 25 28
6. E. Trallero-Araguas, J.A. Rodrigo-Pendas, and A. Selva-O'Callaghan Usefulness of anti-p155 autoantibody for diagnosing cancer-Associated dermatomyositis: a systematic review and meta-Analysis Arthritis Rheum 64 2012 523 532
7. K. Fujikawa, A. Kawakami, and K. Kaji Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-Aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-center, cross-sectional study Scand J Rheumatol 38 2009 263 267
8. K. Hoshino, Y. Muro, K. Sugiura, Y. Tomita, R. Nakashima, and T. Mimori Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis Rheumatology 49 2010 1726 1733
9. E. Trallero-Araguas, M. Labrador-Horrillo, and A. Selva-O'Callaghan Cancer-Associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy Medicine (Baltimore) 89 2010 47 52
10. N. Ikeda, K. Takahashi, Y. Yamaguchi, M. Inasaka, M. Kuwana, and Z. Ikezawa Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients J Dermatol 38 2011 973 979
11. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 1975 344 347
12. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (second of two parts) N Engl J Med 292 1975 403 407
13. R.L. Euwer, and R.D. Sontheimer Amyopathic dermatomyositis: a review J Invest Dermatol 100 1993 124S 127S
14. R.Q. Klein, C.A. Bangert, and M. Costner Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis Br J Dermatol 159 2008 887 894
15. M. Yassaee, D. Fiorentino, and J. Okawa Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument Br J Dermatol 162 2010 669 673
16. D.F. Fiorentino, L.S. Chung, and L. Christopher-Stine Most patients with cancer-Associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma Arthritis Rheum 65 2013 2954 2962
17. H. Chinoy, N. Fertig, C.V. Oddis, W.E. Ollier, and R.G. Cooper The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-Associated myositis Ann Rheum Dis 66 2007 1345 1349
18. M. Fujimoto, Y. Hamaguchi, and K. Kaji Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins Arthritis Rheum 64 2012 513 522
19. E.H. Kang, R. Nakashima, and T. Mimori Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis BMC Musculoskelet Disord 11 2010 223
20. J. Wang, G. Guo, G. Chen, B. Wu, L. Lu, and L. Bao Meta-Analysis of the association of dermatomyositis and polymyositis with cancer Br J Dermatol 169 2013 838 847
21. E.H. Kang, M. Kuwana, and Y. Okazaki Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients Mod Rheumatol 24 2014 945 948
22. L.G. Rider, M. Shah, and G. Mamyrova The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies Medicine (Baltimore) 92 4 2013 223 243
23. H. Gunawardena, L.R. Wedderburn, and J. North Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis Rheumatology 47 2008 324 328
24. M. Shah, I.N. Targoff, M.M. Rice, F.W. Miller, and L.G. Rider Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis Arthritis Rheum 65 2013 1934 1941
25. C.J. Burd, H.K. Kinyamu, F.W. Miller, and T.K. Archer UV radiation regulates Mi-2 through protein translation and stability J Biol Chem 283 2008 34976 34982
26. M.H. Petri, M. Satoh, and B.T. Martin-Marquez Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara Arthritis Res Ther 15 2 2013 R48
27. A. Valenzuela, L. Chung, L. Casciola-Rosen, and D. Fiorentino Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis JAMA Dermatol 150 2014 724 729
28. D. Fiorentino, L. Chung, J. Zwerner, A. Rosen, and L. Casciola-Rosen The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study J Am Acad Dermatol 65 2011 25 34